Skip to content

EFFECT OF DASH DIET AND AEROBIC EXERCISES ON PREMENSTRUAL SYNDROME

EFFECT OF DASH DIET AND AEROBIC EXERCISES ON PREMENSTRUAL SYNDROME

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05395169
Enrollment
50
Registered
2022-05-27
Start date
2022-06-01
Completion date
2022-10-01
Last updated
2022-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual Tension

Brief summary

Hypothesis: There will be no effect of the DASH diet and aerobic exercise on premenstrual syndrome. Statement of the problem: Do the DASH diet and aerobic exercise have an effect on premenstrual syndrome?

Detailed description

For some women, symptoms of PMS may be so severe that they miss work or school. Physical activity is a suitable method for the treatment of PMS and is the best method for all women to reduce pressure and balance the brain's chemical secretion. It seems that physical activity by increasing endorphins and reducing adrenal cortisol leads to the improvement of symptoms of PMS. DASH diet has been suggested to play an important role in the development, and treatment of some psychological disorders. For instance, it has been reported that a diet rich in fish, folate, and B-vitamins can alleviate the manifestations of depression. An established association was also shown between the dietary glycemic index (GI) and psychological diseases, depressive disorder, and mental functioning. Diets containing of junk foods (high energy and low nutritional) have been shown to increase the risk of mental illness, but a healthy diet is associated with less depressive symptoms and can improve mood .

Interventions

OTHERdietary supplement ,electronic treadmill ,DASH diet.

Control group Will be receive medical treatment for 12 weeks. Study group Will be receive the same medication as in control group in addition to DASH diet and aerobic exercise for 12 weeks.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Fifty adolescent females were diagnosed with premenstrual syndrome. * Their age will be ranged from 15-to 25 years (3 years post-puberty). * Their body mass index (BMI) will range from 18-25.9 kg/m2. * All are of regular menstrual cycles. * All of them suffer from moderate and severe PMS.

Exclusion criteria

* Any pathologic findings in the pelvic cavity as a polycystic ovarian syndrome, endometriosis, and pelvic inflammatory diseases. * Having irregular menstruation. * Any metabolic diseases. * Any history of gynecological intervention.

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue scale (VAS)assessment will be take 12 weeksVisual analogue scale (VAS): Degrees of menstrual pain will be assessed using a VAS for all participants in both groups (A&B) before and after treatment, which is a method of representing .participants pain on a 10 cm linear scale. A score of zero mean a very low degree of pain and 10 mean a very high degree of pain
Menstrual Distress Questionnaire (MDQ)assessment will be take 12 weeksMenstrual Distress Questionnaire (MDQ): The subjects decreased activity, lower back pain, tension or anxiety, breast tenderness, and headaches will assess for all participants in both group before and after treatment using Menstrual Distress Questionnaire (MDQ) .Each item will be score on a 5-point likert scale ,with 1 being no pain at all follow by mild pain, moderate pain, slightly sever pain ,and extremely severe pain.

Contacts

Primary ContactAzaa Barmoud, professor
drazzakassab@yahoo.com01008410312

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026